Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Addiction Medicine Training topic

No spam. Unsubscribe anytime.

Addiction medicine fellowship highlights training expansion, calls for continued state support

2522628 · March 7, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

University of Minnesota and Hennepin Healthcare faculty described the Addiction Medicine Fellowship to the House committee, detailing a 12‑month subspecialty program that trains physicians to treat substance use disorders, the program’s recent expansion supported by a $540,000 biennial appropriation, and graduates’ placements across Minnesota.

Dr. Sheila Specker, program director for the University of Minnesota Addiction Medicine Fellowship, and colleagues described the fellowship’s clinical curriculum, sites and recent growth to the House Higher Education Finance and Policy Committee.

Specker told the committee the fellowship — a 12‑month clinical program open to physicians from multiple specialties — was accredited by the ACGME in 2018 and traditionally had trained one to three fellows per year. Legislative funding over the past biennium allowed the program to expand so it could support multiple stipends and train four fellows in recent years. Committee staff identified the appropriation as $270,000 in one year and $270,000 in the other (total $540,000 for the biennium) and the panel confirmed the appropriation line when members asked.

Dr. David Peter, associate program director, described core training sites and rotations: detox and withdrawal management, adolescent addiction services, residential treatment experience, a VA comprehensive pain center and a low‑barrier “recovery clinic” or bridge clinic that provides same‑day access for opioid‑use disorder treatment. Fellows also rotate through Hennepin Healthcare’s inpatient consult services and outpatient methadone programs. The curriculum emphasizes pharmacologic management (including opioid medications), motivational interviewing and integrated care for co‑occurring mental health and pain conditions, and trainees also present at professional society meetings and help develop didactic curricula for residencies.

Dr. Charles Reznikov, Hennepin Healthcare faculty and program graduate, described patient cases that illustrated the fellowship’s scope and public‑health value — examples included lifesaving interventions for acute alcohol poisoning, inpatient management of patients with substance‑related infections and telehealth follow‑up with patients in greater Minnesota. Reznikov urged continued stable funding to sustain fellows and faculty: “Deaths from addiction are preventable,” he said, and training more specialists expands access to evidence‑based treatment across urban and rural Minnesota.

Program leaders explained that the legislative stipend support covers a portion of per‑fellow costs (stipends and benefits) but does not fully fund programmatic faculty costs, program administration or the full cost of operating the fellowship; the program relies on institutional support and clinical revenue to cover the remainder. The committee’s questions focused on how fellowship graduates are being placed across the state; program leaders said alumni have taken roles in Duluth/Essentia, southeast Minnesota, Federally Qualified Health Centers and other underserved areas and that they are exploring telehealth and placement strategies to increase reach.

Committee members thanked the witnesses and signaled support for continued funding to sustain and expand the training pipeline.